For over 75 years, we have been strategically investing in African businesses. BII’s expansive footprint across Africa ...

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such ...

In connection with the closing of the GIP Transaction ... time and may contain information that is not purely historical in nature. Such information may include, among other things, projections ...

One way is through biophilic design, rooted in the idea that humans have an inherent connection to nature. This approach, popularized by Richard Louv, emphasizes integrating natural elements into ...

Restoring nature in the UK’s national parks is being held back because nearly 90% of their land remains in the hands of private owners, campaigners say. The Campaign for National Parks (CNP ...

Roche’s new weight loss can­di­date has the ef­fi­ca­cy the Swiss phar­ma was look­ing for. But it al­so comes with a high rate of side ef­fects … ...

MBX Bio­sciences is the lat­est IPO con­tender af­ter sub­mit­ting its pitch for a $114 mil­lion Nas­daq de­but, which will go to­ward … ...

3,4 As the health sector builds on these landmark achievements, it has the opportunity to embrace nature-based solutions—actions that protect, conserve, restore, sustainably use, and manage natural or ...

FRANKFURT, Sept 3 (Reuters) - German academic research publisher Springer Nature is planning to file documents next week announcing its listing plans, kicking off the European initial public ...

Street Talk understands GIP’s local dealmakers, led by former Credit Suisse Australia boss Rob Stewart, submitted a non-binding indicative offer for QAL but have notified the sellers of its ...

GIP, which has a low cost of capital and owns other gas-related assets, is understood to have lenders in place to fund an acquisition. The asset, up for sale through Goldman Sachs, is on Singapore ...